Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon F Keele

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Journal of Virology|July 31, 2015
Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking MotifMatthew W Breed, Samra E Elser, Workineh Torben, et al.
Science (New York, N.Y.)|August 8, 2024
Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primatesFathima N Nagoor Pitchai, Elizabeth J Tanner, Neha Khetan, et al.
Plos Pathogens|June 17, 2022
A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infectionScott P Lawrence, Samra E Elser, Workineh Torben, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Plos Pathogens|June 14, 2012
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escapeKatharine J Bar, Chun-yen Tsao, Shilpa S Iyer, et al.
Nature Communications|April 11, 2015
Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunizationJoseph R Francica, Zizhang Sheng, Zhenhai Zhang, et al.
The Journal of Clinical Investigation|March 16, 2026
Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaquesLars Pache, John K Bui, Lindsay M Klouser, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Journal of Virology|July 31, 2015
Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking MotifMatthew W Breed, Samra E Elser, Workineh Torben, et al.
Science (New York, N.Y.)|August 8, 2024
Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primatesFathima N Nagoor Pitchai, Elizabeth J Tanner, Neha Khetan, et al.
Plos Pathogens|June 17, 2022
A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infectionScott P Lawrence, Samra E Elser, Workineh Torben, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Plos Pathogens|June 14, 2012
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escapeKatharine J Bar, Chun-yen Tsao, Shilpa S Iyer, et al.
Nature Communications|April 11, 2015
Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunizationJoseph R Francica, Zizhang Sheng, Zhenhai Zhang, et al.
The Journal of Clinical Investigation|March 16, 2026
Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaquesLars Pache, John K Bui, Lindsay M Klouser, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Pageof 23